http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Haidi Xu,Yuanshan Li,Baoqiang Xu,Yi Cao,Xi Feng,Mengmeng Sun,Maochu Gong,Yaoqiang Chen 한국공업화학회 2016 Journal of Industrial and Engineering Chemistry Vol.36 No.-
FeWx/Ce0.68Zr0.32O2 (x = 0, 0.35, 0.7, 1.03, 1.38) catalysts with different molar ratios (x) of W/Fe wereprepared for NH3-SCR. The experimental results showed that catalytic performances of catalysts wereobviously improved by adjusting the molar ratio of W/Fe. FeW1.03/Ce0.68Zr0.32O2 catalyst with W/Fe of1.03 displayed the best catalytic performance, it could obtain higher than 95% NOx conversion and nearly100% N2 selectivity in the temperature range of 250–435 8C. The characterization results indicated thatmore active species of Fe3+, chemical adsorbed oxygen species and surface acid sites would togethercontribute to the excellent NH3-SCR performance of FeW1.03/Ce0.68Zr0.32O2 catalyst.
Peng Song,Yang Hai,Xin Wang,Longhe Zhao,Baoqiang Chen,Peng Cui,Qin-Jian Xie,Lan Yu,Yang Li,Zhengrong Wu,Hong Yu Li 대한약학회 2018 Archives of Pharmacal Research Vol.41 No.4
Realgar (As4S4), as an arsenic sulfide mineraldrug, has a good therapeutic reputation for anticancer inTraditional Chinese Medicine, and has recently beenreported to inhibit angiogenesis in tumor growth. However,considering the poor solubility and low bioavailability ofrealgar, large dose of realgar and long period of treatmentare necessary for achieving the effective blood medicineconcentration. In present study, we resolved the crucialproblem of poor solubility of realgar by using intrinsicbiotransformation in microorganism, and investigatedunderlying mechanisms of realgar transforming solution(RTS) for antiangiogenesis. Our results demonstrated thatRTS had a strong activity to inhibit HUVECs proliferation,migration, invasion, and tube formation. Moreover, RTSinhibited VEGF/bFGF-induced phosphorylation ofVEGFR2 and the downstream protein kinases includingERK, FAK, and Src. In vivo zebrafish and chickenchorioallantoic membrane model experiments showed thatRTS remarkably blocked angiogenesis. Finally, comparedwith the control, administration of 2.50 mg/kg RTSreached more than 50% inhibition against H22 tumorallografts in KM mice, but caused few toxic effects in thehost. The antiangiogenic effect was indicated by CD31immunohistochemical staining and alginate-encapsulatedtumor cell assay. In summary, our findings suggest thatRTS inhibits angiogenesis and may be a potential drugcandidate in anticancer therapy.